Literature DB >> 10889619

Assessing depression in palliative care patients using the visual analogue scale: a pilot study.

N Lees1, M Lloyd-Williams.   

Abstract

It is widely recognised that depression is not detected and therefore not treated in patients who are terminally ill. It is difficult to distinguish depression from sadness at the end of life and many of the criteria for diagnosing depression are not appropriate in the terminally ill patient. There has been considerable interest in using screening tools at the time of referral or admission to a hospice, but to date none of these have been validated for use in palliative care patients. This pilot study of 25 patients admitted to a hospice found that a 100-mm linear visual analogue scale (VAS) correlated well with both the depression sub scale and total score of the Hospital Anxiety and Depression Scale (HADS) and was found to be quick and easy to complete by most patients. The finding suggest that the VAS may be useful as a screening tool for depression in patients with advanced metastatic disease and that larger studies comparing VAS to clinical psychiatric interviews should be undertaken.

Entities:  

Mesh:

Year:  1999        PMID: 10889619     DOI: 10.1046/j.1365-2354.1999.00180.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  10 in total

1.  Auricular acupuncture, education, and smoking cessation: a randomized, sham-controlled trial.

Authors:  Ian D Bier; Jeffrey Wilson; Pat Studt; Mary Shakleton
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

2.  Symptom Management and Psychosocial Needs of Adults With Acute Myeloid Leukemia During Induction Treatment: A Pilot Study.

Authors:  Tara A Albrecht; Michael Boyiadzis; R K Elswick; Angela Starkweather; Margaret Rosenzweig
Journal:  Cancer Nurs       Date:  2017 Nov/Dec       Impact factor: 2.592

3.  A Single-Item Visual Analogue Scale (VAS) Measure for Assessing Depression Among College Students.

Authors:  Zhiyong Huang; Iliana V Kohler; Fabrice Kämpfen
Journal:  Community Ment Health J       Date:  2019-09-17

4.  Frequency of depression among oncology outpatients and association with other symptoms.

Authors:  Wadih Rhondali; Elise Perceau; Julien Berthiller; Pierre Saltel; Veronique Trillet-Lenoir; Olivier Tredan; Jean-Pierre Coulon; Eduardo Bruera; Marilene Filbet
Journal:  Support Care Cancer       Date:  2012-02-17       Impact factor: 3.603

5.  Patients in palliative care-Development of a predictive model for anxiety using routine data.

Authors:  Sonja Hofmann; Stephanie Hess; Carsten Klein; Gabriele Lindena; Lukas Radbruch; Christoph Ostgathe
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

6.  DoloTest in General Practice Study: Sensitivity and Specificity Screening for Depression.

Authors:  Kim Kristiansen; Pernille Lyngholm-Kjaerby; Claus Moe
Journal:  Int J Family Med       Date:  2012-12-06

7.  Influence of progressive fluid restriction on mood and physiological markers of dehydration in women.

Authors:  Nathalie Pross; Agnès Demazières; Nicolas Girard; Romain Barnouin; Francine Santoro; Emmanuel Chevillotte; Alexis Klein; Laurent Le Bellego
Journal:  Br J Nutr       Date:  2012-04-13       Impact factor: 3.718

Review 8.  Screening for emotional distress in cancer patients: a systematic review of assessment instruments.

Authors:  Andrea Vodermaier; Wolfgang Linden; Christopher Siu
Journal:  J Natl Cancer Inst       Date:  2009-10-13       Impact factor: 13.506

Review 9.  End-of-life issues in the acute and critically ill patient.

Authors:  Eric A Savory; Catherine A Marco
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-04-22       Impact factor: 2.953

10.  Effects of changes in water intake on mood of high and low drinkers.

Authors:  Nathalie Pross; Agnès Demazières; Nicolas Girard; Romain Barnouin; Déborah Metzger; Alexis Klein; Erica Perrier; Isabelle Guelinckx
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.